Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 40Congress 0Executive branch 0Insiders 40
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

DYN · $50K+ · 40 trades

Trades
40
Buys 0 · Sells 40
People
4
Stocks
1
Disclosed value
$114M
range midpoints · Congress & executive
Filed late
1
  1. ▼ SELLJohn Cox CEO & PresidentDYN Dyne Therapeutics, Inc.$107Kdisclosed Sep 8 · filed the same day
  2. ▼ SELLDouglas Kerr Chief Medical OfficerDYN Dyne Therapeutics, Inc.$91.2Kdisclosed Sep 8 · filed 4 days after the trade
  3. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$34Mdisclosed Aug 17 · filed 3 days after the trade
  4. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$2.5Mdisclosed Aug 17 · filed 4 days after the trade
  5. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$7Mdisclosed Aug 17 · filed 4 days after the trade
  6. ▼ SELLJohn Cox CEO & PresidentDYN Dyne Therapeutics, Inc.$131Kdisclosed Aug 17 · filed 4 days after the trade
  7. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$12Mdisclosed Aug 17 · filed 3 days after the trade
  8. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$8.1Mdisclosed Aug 17 · filed 3 days after the trade
  9. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.7Mdisclosed Aug 17 · filed 4 days after the trade
  10. ▼ SELLDirk Kersten DirectorDYN Dyne Therapeutics, Inc.$6.5Mdisclosed Jul 29 · filed 2 days after the trade
  11. ▼ SELLDirk Kersten DirectorDYN Dyne Therapeutics, Inc.$140Kdisclosed Jul 29 · filed 2 days after the trade
  12. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$118Kdisclosed Jul 8 · filed 1 day after the trade
  13. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$5.8Mdisclosed Jul 8 · filed 2 days after the trade
  14. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.1Mdisclosed Jul 8 · filed 1 day after the trade
  15. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$276Kdisclosed Jul 8 · filed 1 day after the trade
  16. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$2.9Mdisclosed Jul 8 · filed 1 day after the trade
  17. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.4Mdisclosed Jul 8 · filed 1 day after the trade
  18. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$351Kdisclosed Jul 8 · filed 1 day after the trade
  19. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$699Kdisclosed Jul 8 · filed 1 day after the trade
  20. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$2.3Mdisclosed Jul 8 · filed 2 days after the trade
  21. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$2.9Mdisclosed Jul 8 · filed 2 days after the trade
  22. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$860Kdisclosed Jun 30 · filed 1 day after the trade
  23. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.4Mdisclosed Jun 30 · filed 4 days after the trade
  24. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.7Mdisclosed Jun 30 · filed 4 days after the trade
  25. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.1Mdisclosed Jun 30 · filed 1 day after the trade